Peculiarities of nutrition of patients with metabolic syndrome in the aspect of treatment and prevention

Author:

Khatsko ,Mykhaylenko ,Danylchuk ,Kornovan ,Lahoda

Abstract

The hallmark of metabolic syndrome (MS) is the associated risks of cardiovascular disease and type 2 diabetes, as well as other harmful conditions such as non-alcoholic fatty liver disease, etc. In this article, we would like to highlight the available scientific evidence on the relationship between lifestyle changes and MS and its components in order to obtain recommendations for the prevention and treatment of MS. Body weight (BW) reduction through calorie-restricted diets, along with increased energy expenditure through physical activity, has been shown to aid in the prevention and treatment of MS. A Mediterranean diet with or without calorie restriction is an effective component of treatment. Due to the increased consumption of unsaturated fats, primarily from olive oil, and to emphasize the consumption of legumes, cereals (whole grains), fruits, vegetables, nuts, fish and low- fat dairy products, as well as moderate alcohol consumption. Other dietary patterns (DASH, Scandinavian and vegetarian diets) have also been suggested as alternatives for the treatment and prevention of MS. A mandatory condition is to stop smoking and reduce the consumption of sweetened beverages. These approaches are not effective in all patients, and more research is needed to determine the most appropriate therapy for MS. In summary, a healthy lifestyle is critical for preventing or delaying the onset of MS in susceptible individuals and preventing cardiovascular disease and type 2 diabetes in those who already have MS. The recommendations provided in this article should help patients and physicians understand and implement the most effective lifestyle modification approaches to prevent metabolic syndrome and improve cardiometabolic status.

Publisher

Ukrainian Diabetology Association

Reference76 articles.

1. Balkau B. Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR) / B. Balkau, M. A. Charles // Diabetic medicine. – 1999. – Vol. 16, N 5. – P. 442–443. – DOI: 10.1046/j.1464-5491.1999.00059.x

2. 2. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man / D. R. Matthews, J. P. Hosker, A. S. Rudenski [et al.] // Diabetologia. – 1985. – Vol. 28. – P. 412–419.

3. 3. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) // JAMA. – 2001. – Vol. 285, N 19. – P. 2486–2497. – DOI: 10.1001/jama.285.19.2486

4. 4. Follow-up report on the diagnosis of diabetes mellitus / S. Genuth, K. G. Alberti, P. Bennett [et al.] // Diabetes Care. – 2003. – Vol. 26, N 11. – P. 3160–3167. – DOI: 10.2337/diacare.26.11.3160

5. 5. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity / K. G. Alberti, R. H. Eckel, S. M. Grundy [et al.] // Circulation. – 2009. – Vol. 120, N 16. – P. 1640–1645. – DOI: 10.1161/CIRCULATIONAHA.109.192644

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3